Memantine and Donepezil Hydrochlorides Extended-release is a Oral Capsule, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Amneal Pharmaceuticals Ny Llc. The primary component is Memantine Hydrochloride; Donepezil Hydrochloride.
Product ID | 69238-1247_397c2949-6b6e-4927-9e98-b0dfda3a5449 |
NDC | 69238-1247 |
Product Type | Human Prescription Drug |
Proprietary Name | Memantine and Donepezil Hydrochlorides Extended-release |
Generic Name | Memantine And Donepezil |
Dosage Form | Capsule, Extended Release |
Route of Administration | ORAL |
Marketing Start Date | 2017-02-01 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA208328 |
Labeler Name | Amneal Pharmaceuticals NY LLC |
Substance Name | MEMANTINE HYDROCHLORIDE; DONEPEZIL HYDROCHLORIDE |
Active Ingredient Strength | 28 mg/1; mg/1 |
Pharm Classes | NMDA Receptor Antagonists [MoA],N-methyl-D-aspartate Receptor Antagonist [EPC],Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |